Helius Therapeutics
Latest news of Helius Therapeutics. Based in Auckland, New Zealand, Helius Therapeutics has grown into one of the country’s largest and most advanced cannabis medicines producers.
-
NZ engineers to drive better outcomes for cannabis patients
New Zealand’s largest medicinal cannabis company, Helius Therapeutics, has launched an industry collaboration with the University of Canterbury’s Engineering Faculty. It sees Helius working together over the coming months with Biomedical, Mechanical, and Mechatronics Engineering students supervised by Distinguished Professor Geoff Chase. The final-year student project centres around how accurately the…
Read More » -
NZ doctors have one key advantage over Aussie – Helius
“Australia is ahead when it comes to the production and uptake of medicinal cannabis, yet New Zealand’s scheme gives doctors and patients one key advantage,” says Julie Curphey, Chief Commercial Officer (CCO) at Helius Therapeutics. Ms Curphey’s comments follow her recent attendance at the 2022 United In Compassion (UIC) Australian Medicinal Cannabis Symposium…
Read More » -
New phase for Helius as David Darling joins board
David Darling has been appointed as an independent director on the board at Helius Therapeutics – New Zealand’s largest medicinal cannabis company. Mr Darling has had an extensive career working on the development, growth and international commercialisation of life sciences and biotechnology products businesses. “Helius is at the forefront of tomorrow’s plant-based…
Read More » -
Kiwi medicinal cannabis to be exported this year
December marked three years since New Zealand’s Parliament unanimously passed legislation to enable a local medicinal cannabis industry. With overseas products limited and expensive, finally Kiwi patients would have legal access to quality local products at affordable prices. After a myriad of industry regulations were finalised, New Zealand’s scheme and…
Read More » -
Medicinal cannabis industry now in delivery phase
This month marks three years since Parliament unanimously passed the legislation to enable a New Zealand medicinal cannabis industry. With overseas products limited and expensive, finally Kiwi patients would have legal access to quality local products at affordable prices. After a myriad of industry regulations were finalised, New Zealand’s scheme and…
Read More » -
MedCan 2022 perfectly timed for local cannabis industry
“With New Zealand’s cannabis businesses now delivering for Kiwi patients and set to export, February’s MedCan is perfectly timed to bring the sector and many key stakeholders together,” says Carmen Doran, Chief Executive of Helius Therapeutics. Helius is the foundation sponsor of the country’s largest medicinal cannabis summit, MedCan 2022.…
Read More » -
NZ doctors’ interest in medicinal cannabis grows
A leading medicinal cannabis online education platform is encouraged by the strong interest it’s now seeing from New Zealand’s key healthcare professionals. It follows genuine concern that doctors lack sufficient knowledge about medicinal cannabis to prescribe it to patients. About 1,250 doctors and pharmacists have now registered on MCinfo.com – a dedicated…
Read More » -
First key ‘Cannabis for pets’ study conducted
A New Zealand company that’s set to be among the first in the world to register cannabis medicines for pets has successfully completed its first study involving dogs. Hale Animal Health’s Managing Director, Leila de Koster, says while the research is commercially sensitive, and the findings will be closely guarded,…
Read More » -
Helius appoints Director of R&D
Marten Vos has been appointed Director of Research & Development at Helius Therapeutics. “Helius is squarely focused on building and driving its R&D capability, with this new senior role reflecting just that. Successfully competing on the world stage means we need to be a leader in the R&D space, delivering…
Read More » -
Candace Kinser appointed chair of Helius Therapeutics
Candace Kinser has been appointed chair of the board at Helius Therapeutics. The accomplished chief executive and non-executive board director brings significant experience in high-growth start-ups, technology transformation, healthcare, biotech, and agribusiness commercialisation. Ms Kinser says she was attracted to Helius’ founding motivation to develop novel prescription medicines for patients…
Read More »
